4104
佳醫
-0.20 (-0.27%)72.60194成交張數15.28本益比1.39股價淨值比5.92%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 212 | 98 | 37.6% | 1.95 | 52.10 | 9.8% | 4.5% | 3.2 | 2.9 |
| 2026Q1 | 195 | 96 | 38.1% | 1.70 | 51.14 | 9.0% | 4.3% | 2.2 | 1.9 |
| 2025Q4 | 190 | 92 | 38.2% | 1.67 | 53.58 | 8.9% | 4.1% | 2.4 | 2.3 |
| 2025Q3 | 188 | 89 | 39.8% | 1.63 | 51.68 | 9.1% | 4.0% | -2.5 | -2.8 |
| 2025Q2 | 184 | 85 | 41.4% | 1.55 | 51.93 | 9.2% | 4.4% | 1.0 | 0.8 |
| 2025Q1 | 188 | 86 | 42.2% | 1.53 | 52.44 | 9.2% | 4.2% | -14.5 | -14.8 |
| 2024Q4 | 204 | 90 | 44.2% | 1.47 | 54.90 | 8.8% | 4.0% | -18.0 | -18.3 |
| 2024Q3 | 219 | 88 | 49.6% | 1.34 | 53.71 | 8.8% | 3.9% | 38.7 | 38.3 |
| 2024Q2 | 177 | 86 | 38.7% | 1.59 | 55.55 | 9.2% | 4.5% | -3.1 | -3.4 |
| 2024Q1 | 184 | 83 | 43.1% | 1.46 | 53.65 | 9.0% | 4.2% | 7.2 | 7.0 |
| 2023Q4 | 181 | 86 | 39.6% | 1.60 | 55.35 | 8.9% | 4.3% | 0.6 | 0.1 |
| 2023Q3 | 176 | 86 | 38.3% | 1.62 | 55.04 | 8.6% | 4.2% | 1.9 | 1.5 |
| 2023Q2 | 169 | 83 | 38.2% | 1.57 | 55.93 | 9.1% | 4.5% | -0.0 | -0.2 |
| 2023Q1 | 167 | 79 | 40.2% | 1.53 | 53.47 | 9.1% | 4.4% | -1.5 | -1.6 |
| 2022Q4 | 165 | 82 | 37.5% | 1.66 | 55.33 | 8.4% | 4.2% | 0.6 | -0.0 |
| 2022Q3 | 162 | 81 | 37.2% | 1.67 | 54.98 | 8.7% | 4.4% | 2.5 | 2.2 |
| 2022Q2 | 160 | 78 | 38.7% | 1.63 | 55.34 | 8.5% | 4.2% | 1.6 | 1.3 |
| 2022Q1 | 154 | 76 | 38.2% | 1.74 | 53.58 | 8.7% | 4.3% | 1.6 | 1.2 |
| 2021Q4 | 151 | 77 | 35.5% | 1.88 | 54.82 | 7.9% | 4.2% | 3.1 | 3.1 |
| 2021Q3 | 145 | 75 | 34.7% | 1.92 | 53.33 | 7.7% | 4.1% | 0.3 | 0.2 |
| 2021Q2 | 146 | 74 | 36.1% | 1.84 | 52.51 | 7.5% | 3.9% | 2.8 | 2.4 |
| 2021Q1 | 143 | 72 | 36.2% | 1.83 | 51.11 | 7.9% | 3.9% | 3.3 | 2.1 |
| 2020Q4 | 140 | 76 | 31.6% | 2.11 | 53.78 | 7.9% | 4.1% | 4.6 | 4.5 |
| 2020Q3 | 138 | 75 | 31.3% | 2.11 | 53.22 | 7.6% | 3.9% | -0.3 | -0.3 |
| 2020Q2 | 139 | 74 | 32.8% | 2.04 | 52.36 | 7.7% | 3.8% | 5.1 | 5.0 |
| 2020Q1 | 145 | 71 | 40.2% | 1.74 | 50.41 | 7.4% | 3.6% | -0.7 | -0.8 |
| 2019Q4 | 138 | 69 | 37.3% | 1.78 | 54.21 | 7.5% | 3.7% | 8.5 | 8.2 |
| 2019Q3 | 139 | 69 | 38.9% | 1.75 | 53.67 | 7.5% | 3.7% | -0.9 | -1.0 |
| 2019Q2 | 146 | 68 | 43.2% | 1.85 | 52.83 | 7.1% | 3.3% | 2.5 | 2.4 |
| 2019Q1 | 145 | 70 | 40.7% | 1.96 | 54.77 | 6.9% | 3.2% | 1.9 | 1.8 |
| 2018Q4 | 140 | 68 | 40.3% | 1.95 | 53.12 | 6.8% | 3.1% | 7.3 | 7.1 |
| 2018Q3 | 139 | 67 | 40.7% | 1.91 | 52.39 | 6.5% | 3.0% | -3.2 | -3.3 |
| 2018Q2 | 148 | 67 | 44.8% | 1.69 | 52.05 | 6.2% | 2.7% | -3.6 | -3.7 |
| 2018Q1 | 150 | 68 | 43.3% | 1.71 | 52.79 | 5.7% | 2.5% | 1.5 | 1.4 |
| 2017Q4 | 150 | 64 | 46.3% | 1.64 | 50.20 | 6.2% | 2.5% | 0.5 | 0.3 |
| 2017Q3 | 146 | 63 | 45.9% | 1.66 | 49.61 | 6.2% | 2.6% | 2.1 | 2.1 |
| 2017Q2 | 152 | 63 | 48.5% | 1.59 | 49.07 | 6.3% | 2.5% | 0.1 | 0.1 |
| 2017Q1 | 152 | 65 | 46.6% | 1.64 | 50.67 | 5.9% | 2.5% | -7.6 | -7.6 |
| 2016Q4 | 168 | 65 | 50.6% | 1.62 | 51.05 | – | – | 4.8 | 4.8 |
| 2016Q3 | 162 | 65 | 49.6% | 1.68 | 50.95 | – | – | 3.1 | 2.9 |